Hunan Xiangyikang Pharmaceutical

Hunan Xiangyikang Pharmaceutical is a Chinese pharmaceutical manufacturing company and a key subsidiary of Hunan Erkang Pharmaceutical (SZ: 300267). Founded in 2009 and based in Yiyang, Hunan, the company specializes in the development, large-scale production, and sale of Active Pharmaceutical Ingredients (APIs), pharmaceutical excipients, and chemical intermediates. Its primary product portfolio features a robust range of sulfonamide antibiotics, such as Sulfadiazine and Sulfadimidine, as well as gastrointestinal agents including Bismuth Potassium Citrate. The company maintains advanced GMP-certified facilities and serves as a major manufacturing hub for its parent group, supplying critical raw materials and finished drug products to the global healthcare and life science sectors.